Halozyme Therapeutics, Inc.San Diego, CA, United States (NASDAQ (GM): HALO)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Halozyme Financial Market Data

Current Information
Last Close 22-Sep-2008 $7.03 Price/ Sales Ratio 110.81
52-Week High $9.46 Price/ Book Ratio 15.43
52-Week Low $4.19 Price/ Earnings Ratio --
60-Month Beta -- Price/ Cash Flow Ratio --
Market Cap (mil.) $563.1 Return on Assets (38.1%)
Shares Outstanding (mil.) 80.1 Return on Equity (66.5%)
Dividend Rate -- Current Ratio 9.15
Dividend Yield -- Long-Term Debt/Equity --
# of Institutional Holders 80 % Owned by Institutions 32.0%
Latest Short Interest Ratio 18.88 Latest Net Insider Transactions 40,000.00

Growth Rates 12 Month 36 Month 60 Month
Revenue Growth 139.2% 11,979.1% 8,825.1%
EPS Growth 0.0% 0.0% 0.0%
Dividend Growth 0.0% 0.0% 0.0%
Edgar Online logo
This data is provided as per license from EDGAR Online